Fund Holdings — Vivo Capital, LLC

Total Portfolio Value:
$1.10B
Total Bought:
$186.15M
Total Sold:
$345.91M
Net Transaction:
-$159.76M
Notable People:
Edgar George Engleman, Frank Fang-Chien Kung, Shan (Nmn) Fu, Michael J. Chang, Gaurav Aggarwal
Securities
▲▼
SharesValue
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Trevi Therapeutics, Inc.(TRVI)5,094,6685,094,6680$60.78M$95.02M8.68%+$34.24M
Praxis Precision Medicines, Inc.(PRAX)338,895271,116-67,779$109.19M$90.77M8.29%-$18.42M
Erasca, Inc.(ERAS)12,151,4804,127,412-8,024,068$196.61M$75.61M6.90%-$121.00M
ArriVent BioPharma, Inc.(AVBP)885,9161,682,097+796,181$20.44M$58.44M5.34%+$38.00M
ABIVAX Société AnonymeADS(ABVX)239,539414,899+175,360$26.67M$55.29M5.05%+$28.62M
Tango Therapeutics, Inc.(TNGX)2,154,7801,379,769-775,011$45.08M$43.13M3.94%-$1.95M
Corvus Pharmaceuticals, Inc.(CRVS)2,805,8162,805,8160$41.05M$41.92M3.83%+$869.8K
Bright Minds Biosciences Inc.(DRUG)557,172557,1720$40.66M$39.11M3.57%-$1.54M
Sinovac Biotech, Ltd.SHS(SVA)5,903,0005,903,0000$38.19M$38.19M3.49%$0
Tenax Therapeutics, Inc.(TENX)208,3332,500,000+2,291,667$3.33M$36.38M3.32%+$33.04M
Aclaris Therapeutics, Inc.(ACRS)6,666,6666,694,637+27,971$25.00M$35.41M3.23%+$10.41M
Dyne Therapeutics, Inc.(DYN)1,557,4661,557,4660$28.24M$34.59M3.16%+$6.35M
Dianthus Therapeutics, Inc.(DNTH)353,998353,9980$29.71M$34.51M3.15%+$4.80M
Alto Neuroscience, Inc.(ANRO)1,035,5511,208,858+173,307$23.28M$31.90M2.91%+$8.62M
DBV Technologies S.A.ADS(DBVT)2,667,5691,844,758-822,811$55.73M$30.25M2.76%-$25.47M
SAB Biotherapeutics, Inc.(SABS)11,420,0007,299,909-4,120,091$43.74M$28.47M2.60%-$15.27M
MoonLake ImmunotherapeuticsCL A(MLTX)1,000,0001,400,000+400,000$18.64M$27.26M2.49%+$8.62M
LB Pharmaceuticals Inc(LBRX)800,000800,0000$19.73M$25.96M2.37%+$6.24M
Minerva Neurosciences, Inc.(NERV)4,322,7474,322,7470$26.04M$23.99M2.19%-$2.05M
Design Therapeutics, Inc.(DSGN)1,612,9031,612,9030$17.16M$23.34M2.13%+$6.18M
ORIC Pharmaceuticals, Inc.(ORIC)1,848,7861,848,7860$23.42M$20.02M1.83%-$3.40M
CAMP4 THERAPEUTICS CORPORATION(CAMP)4,246,5684,246,5680$18.73M$18.56M1.69%-$169.9K
Faeth Therapeutics, Inc.(FTH)722,020722,0200$22.76M$18.05M1.65%-$4.71M
Achieve Life Sciences Inc.02,751,032+2,751,032$0$17.96M1.64%+$17.96M
Compass Therapeutics, Inc.(CMPX)9,545,4667,757,060-1,788,406$50.50M$16.99M1.55%-$33.51M
AN2 Therapeutics Inc3,153,6403,153,6400$10.79M$15.26M1.39%+$4.48M
Editas Medicine, Inc.(EDIT)03,555,250+3,555,250$0$11.52M1.05%+$11.52M
Geron Corporation(GERN)8,671,7978,671,7970$12.92M$11.10M1.01%-$1.82M
Odyssey Therapeutics Inc0575,000+575,000$0$10.76M0.98%+$10.76M
Eupraxia Pharmaceuticals Inc.(EPRX)1,350,0001,350,0000$9.77M$8.92M0.81%-$850.5K
OnKure Therapeutics, Inc.(OKUR)1,927,7101,927,7100$7.98M$8.79M0.80%+$809.6K
Olema Pharmaceuticals, Inc.(OLMA)671,843671,8430$10.02M$8.40M0.77%-$1.61M
Monopar Therapeutics Inc.(MNPR)90,50090,5000$4.96M$8.38M0.77%+$3.42M
Aura Biosciences, Inc.(AURA)01,166,667+1,166,667$0$8.28M0.76%+$8.28M
Surrozen, Inc.(SRZN)260,000260,0000$7.57M$6.75M0.62%-$826.8K
ALX Oncology Holdings Inc.(ALXO)3,184,7133,184,7130$6.39M$6.59M0.60%+$207.0K
Satellos Bioscience Inc.(MSLE)813,666813,6660$4.58M$6.33M0.58%+$1.75M
Avalo Therapeutics, Inc.(AVTX)0275,000+275,000$0$5.08M0.46%+$5.08M
PepGen Inc.(PEPG)2,325,0002,325,0000$4.12M$4.18M0.38%+$69.8K
Valneva SEADS(VALN)0763,199+763,199$0$3.99M0.36%+$3.99M
Sera Prognostics, Inc.(SERA)1,650,4401,650,4400$3.35M$3.00M0.27%-$346.6K
Unicycive Therapeutics, Inc.(UNCY)1,789,916550,000-1,239,916$11.78M$2.58M0.24%-$9.20M
Instil Bio, Inc.(TIL)292,743292,7430$2.41M$2.25M0.21%-$161.0K
InMed Pharmaceuticals Inc.(INM)0798,377+798,377$0$1.24M0.11%+$1.24M
Bolt Biotherapeutics Inc72,41472,4140$292.6K$278.8K0.03%-$13.8K
Pasithea Therapeutics Corp.(KTTA)2,100,000465,471-1,634,529$1.56M$239.9K0.02%-$1.32M
Precision BioSciences, Inc.(DTIL)4,6754,6750$25.7K$36.7K0.00%+$11.0K
Cogent Biosciences, Inc.(COGT)422,3000-422,300$16.25M$0—-$16.25M
COMPASS Pathways plcADS(CMPS)200,0000-200,000$1.11M$0—-$1.11M
Soleno Therapeutics Inc294,9090-294,909$9.87M$0—-$9.87M
Terns Pharmaceuticals Inc1,334,4180-1,334,418$70.35M$0—-$70.35M
Veradermics, Incorporated(MANE)300,0000-300,000$18.95M$0—-$18.95M
Viridian Therapeutics, Inc.(VRDN)166,2880-166,288$3.25M$0—-$3.25M
Page 1 of 1
Vivo Capital, LLC — 13F Holdings — Q2 2026 | TickerTrail